Explore 3 Stock Ideas & Industry Insights Download Free Report

Diversified Opportunities Report

Hims & Hers Health, Inc

Apr 17, 2025

  • HIMS:NYSE
  • Investment Type
    Mid - Cap
  • Risk Level
  • Action
  • Rec. Price (US$)

Section 1: Company Overview and Fundamentals

1.1 Company Overview:

Hims & Hers Health, Inc (NYSE: HIMS) offers a consumer-centric platform designed to support individuals with their health and wellness needs. The platform features access to a network of healthcare providers, a clinically oriented electronic medical records system, digital prescription services, cloud-based pharmacy fulfillment, and personalized care options.

Kalkine’s Diversified Opportunities Report covers the Company Overview, Key positives & negatives, Investment summary, Key investment metrics, Top 10 shareholding, Business updates and insights into company recent financial results, Key Risks & Outlook, Price performance and technical summary, Target Price, and Recommendation on the stock.

Stock Performance:

  • After peaking above $70 in late February 2025, the stock has entered a significant downtrend, losing over 60% of its value.
  • The price is now below both the 21-day and 50-day moving averages, indicating bearish momentum.
  • This RSI value of 40.83suggests the stock is approaching oversold territory (below 30), but not there yet. 

1.2 The Key Positives, Negatives, and Investment summary

1.3 Top 10 shareholders:

The top 10 shareholders together form ~49.91% of the total shareholding, signifying concentrated shareholding. BlackRock Institutional Trust Company, N.A. and The Vanguard Group, Inc are the biggest shareholders, holding the maximum stake in the company at 12.92% and 9.46%, respectively.

1.4 Key Metrics

The graph highlights strong financial growth from 2021 to 2024, with revenue increasing from USD 271.9 million to USD 1,476.5 million, reflecting a 4-year CAGR of 52.65%. Over the same period, net income improved significantly, shifting from a loss of USD 107.7 million in 2021 to a profit of USD 126.0 million in 2024. This indicates a successful transition toward profitability and efficient scaling of the business.

Section 2: Business Updates and Corporate Business Highlights

2.1 Recent Updates:

The below picture gives an overview of the recent updates:

2.2 Insights of FY24:

Section 3: Key Risks & Outlook

Section 4: Stock Recommendation Summary:

4.1 Price Performance and Technical Summary:

Stock Performance:

  • After peaking above $70 in late February 2025, the stock has entered a significant downtrend, losing over 60% of its value.
  • The price is now below both the 21-day and 50-day moving averages, indicating bearish momentum.
  • This RSI value of 40.83suggests the stock is approaching oversold territory (below 30), but not there yet. 

4.2 Fundamental Valuation

Valuation Methodology: P/E Multiple Based Relative Valuation

Markets are trading in a highly volatile zone currently due to certain macroeconomic issues and geopolitical tensions prevailing. Therefore, it is prudent to follow a cautious approach while investing.

Note 1: Past performance is not a reliable indicator of future performance.

Note 2: The reference date for all price data, currency, technical indicators, support, and resistance levels is April 17, 2025. The reference data in this report has been partly sourced from REFINITIV.

Note 3: Investment decisions should be made depending on an individual's appetite for upside potential, risks, holding duration, and any previous holdings. An 'Exit' from the stock can be considered if the Target Price mentioned as per the Valuation and or the technical levels provided has been achieved and is subject to the factors discussed above.

Note 4: The report publishing date is as per the Pacific Time Zone.

Technical Indicators Defined: -

Support: A level at which the stock prices tend to find support if they are falling, and a downtrend may take a pause backed by demand or buying interest. Support 1 refers to the nearby support level for the stock and if the price breaches the level, then Support 2 may act as the crucial support level for the stock.

 Resistance: A level at which the stock prices tend to find resistance when they are rising, and an uptrend may take a pause due to profit booking or selling interest. Resistance 1 refers to the nearby resistance level for the stock and if the price surpasses the level, then Resistance 2 may act as the crucial resistance level for the stock.

Stop-loss: It is a level to protect against further losses in case of unfavorable movement in the stock prices.


Disclaimer-

Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions  and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.

Past performance is not a reliable indicator of future performance.